Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir interaction study with lopinavir/ritonavir and atazanavir/ritonavir in healthy volunteers
NL-OMON30839Phase 1Not yet recruiting
- Sponsor
- Tibotec
- Start
- Oct 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telaprevir, lopinavir, ritonavir and atazanavir in hepatitis C virus infection and human immunodeficiency virus infection (HIV), sponsored by Tibotec. Planned start Oct 2007; status: not yet recruiting.
02
Drugs
telaprevirlopinavirritonaviratazanavir
03
Conditions
hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON30839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30839.